ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Raymond Limet
Gilles Lepage
Claude M. Grondin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Limet, R.
Right arrow Articles by Grondin, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limet, R.
Right arrow Articles by Grondin, C. M.

Ann Thorac Surg 1977;23:529-533
© 1977 The Society of Thoracic Surgeons


Articles

Thromboembolic Complications with the Cloth-Covered Starr-Edwards Aortic Prosthesis in Patients Not Receiving Anticoagulants

Raymond Limet, M.D., Gilles Lepage, M.D., Claude M. Grondin, M.D.*

From the Department of Surgery, Montreal Heart Institute, Montreal, Que, Canada

Accepted for publication October 15, 1976.

* Address reprint requests to Dr. Claude M. Grondin, Montreal Heart Institute, 5000 E Belanger St, Montreal, Que, Canada HIT 1C8

A comparison of the incidence of thromboembolic (TE) episodes was made in three groups of patients who underwent aortic valve replacement with the cloth-covered Starr-Edwards prostheses. Group 1 consisted of patients who received anticoagulants for either the entire period of follow-up or for a period of variable duration, after which these agents were no longer administered. When anticoagulants were stopped, 22 patients were categorized as Group 3 for study. Group 2 comprised patients who never received anticoagulants.

Of the 147 patients followed in Group 1, 14 suffered one episode of TE. Six patients experienced major emboli; 3 of them died. Twenty of the 82 patients followed in Group 2 (no anticoagulants) suffered TE complications. There were 10 episodes of major emboli. Five of the 22 patients in Group 3 suffered an episode (all major) of TE.

It is concluded from this study that anticoagulants should be given permanently to all patients with cloth-covered Starr-Edwards prostheses. Indeed, there is no period after operation when the incidence of TE is so low that anticoagulation may be safely discontinued.




This article has been cited by other articles:


Home page
JAMAHome page
M. H. Eckman, J. R. Beshansky, I. Durand-Zaleski, H. J. Levine, and S. G. Pauker
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves: Does Low Risk Mean High Cost?
JAMA, March 16, 1990; 263(11): 1513 - 1521.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thromboembolic Complications of Current Cardiac Valvular Prostheses
Ann. Thorac. Surg., July 1, 1982; 34(1): 96 - 106.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1977 by The Society of Thoracic Surgeons.